XBI - SPDR S&P Biotech ETF (USD), US78464A8707 | Cbonds
ヒントモードがオンになっています オフ

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US78464A8707
XBI ISIN
上場投資信託(ETF)
ファンドのタイプ
SPDR State Street Global Advisors
プロバイダー
156.5 USD
一口当たり純資産価値(NAV) | 2026/07/01
2006/01/31
設定日
4 年回
配当支払い
CEOILS
CFI
XBI
ティッカー
Formed
ステータス
Equity
投資カテゴリー
Biotech
セクター
USA
投資家所在地
S&P Biotechnology Select Industry Index
ベンチマーク
0.35 %
総保有コスト率(Total Cost Ratio)
10,579.39 百万 USD
ファンド基準価額 | 2026/07/01
10,579.39 百万 USD
株式クラス純資産価値(Share Class NAV) | 2026/07/01
いいえ
UCITS
1 / 3 (11/09/2015)
株式分割

利回り 時点 2026/07/01, NYSE Arca

  • 年初来
    5.06 %
  • 1ヶ月
    -7.93 %
  • 3ヶ月
    1.65 %
  • 6ヶ月
    11.2 %
  • 1年
    62.15 %
  • 3年
    51.47 %
  • 5年
    0.91 %
  • 10年
    143.19 %
「収入支払いを考慮した取引所価格で」

最新データ
比較する要素を追加

相場(XBI)

最も包括的なデータベースを探索

1 000 000

債券

80 234

175 910

ETF&投資信託

70 000

インデックス

最も効率的な方法でポートフォリオを追跡

  • 債券検索
  • ウォッチリスト
  • Excelアドイン

価格推移

ファンドプロファイル

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI プロファイル

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

構造 XBI 時点 2026/06/30

証券 価値
APOGEE THERAPEUTICS INC 1.48%
MODERNA INC 1.41%
TWIST BIOSCIENCE CORP 1.4%
ORUKA THERAPEUTICS INC 1.37%
KYMERA THERAPEUTICS INC 1.35%
VIKING THERAPEUTICS INC 1.3%
PRAXIS PRECISION MEDICINES I 1.29%
ERASCA INC 1.27%
REVOLUTION MEDICINES INC 1.2%
RHYTHM PHARMACEUTICALS INC 1.2%
CG ONCOLOGY INC 1.2%
SELLAS LIFE SCIENCES GROUP I 1.19%
VAXCYTE INC 1.18%
DIANTHUS THERAPEUTICS INC 1.18%
CYTOKINETICS INC 1.17%
NATERA INC 1.16%
SCHOLAR ROCK HOLDING CORP 1.15%
ROIVANT SCIENCES LTD 1.15%
MIRUM PHARMACEUTICALS INC 1.15%
COGENT BIOSCIENCES INC 1.14%
ULTRAGENYX PHARMACEUTICAL IN 1.14%
TRAVERE THERAPEUTICS INC 1.12%
ALKERMES PLC 1.1%
KRYSTAL BIOTECH INC 1.1%
CELCUITY INC 1.1%
RELAY THERAPEUTICS INC 1.09%
SPYRE THERAPEUTICS INC 1.09%
TG THERAPEUTICS INC 1.09%
BEAM THERAPEUTICS INC 1.08%
INSMED INC 1.07%
PROTAGONIST THERAPEUTICS INC 1.07%
ARROWHEAD PHARMACEUTICALS IN 1.06%
VERA THERAPEUTICS INC 1.06%
VERTEX PHARMACEUTICALS INC 1.05%
MADRIGAL PHARMACEUTICALS INC 1.05%
ABBVIE INC 1.03%
BIOGEN INC 1.03%
PTC THERAPEUTICS INC 1.03%
HALOZYME THERAPEUTICS INC 1.03%
UNIQURE NV 1.02%
BRIDGEBIO PHARMA INC 1.02%
CRISPR THERAPEUTICS AG 1.02%
IMMUNITYBIO INC 1.02%
SUMMIT THERAPEUTICS INC 1.01%
IONIS PHARMACEUTICALS INC 1.%
INCYTE CORP 0.99%
AMGEN INC 0.99%
NEUROCRINE BIOSCIENCES INC 0.97%
GILEAD SCIENCES INC 0.96%
REGENERON PHARMACEUTICALS 0.96%
EXELIXIS INC 0.96%
ALNYLAM PHARMACEUTICALS INC 0.96%
BIOMARIN PHARMACEUTICAL INC 0.94%
ACADIA PHARMACEUTICALS INC 0.93%
NUVALENT INC A 0.93%
IMMUNOVANT INC 0.92%
UNITED THERAPEUTICS CORP 0.92%
INTELLIA THERAPEUTICS INC 0.9%
GRAIL INC 0.9%
BIOCRYST PHARMACEUTICALS INC 0.89%
CATALYST PHARMACEUTICALS INC 0.87%
DYNE THERAPEUTICS INC 0.86%
TANGO THERAPEUTICS INC 0.84%
DENALI THERAPEUTICS INC 0.83%
VERACYTE INC 0.82%
IDEAYA BIOSCIENCES INC 0.8%
RECURSION PHARMACEUTICALS A 0.75%
SAREPTA THERAPEUTICS INC 0.74%
ARCUS BIOSCIENCES INC 0.74%
SYNDAX PHARMACEUTICALS INC 0.72%
ARCUTIS BIOTHERAPEUTICS INC 0.71%
MINERALYS THERAPEUTICS INC 0.71%
CELLDEX THERAPEUTICS INC 0.7%
AGIOS PHARMACEUTICALS INC 0.69%
VIRIDIAN THERAPEUTICS INC 0.67%
NOVAVAX INC 0.66%
DISC MEDICINE INC 0.65%
ADMA BIOLOGICS INC 0.61%
IMMUNOME INC 0.59%
PALVELLA THERAPEUTICS INC 0.58%
IOVANCE BIOTHERAPEUTICS INC 0.56%
ABSCI CORP 0.56%
NURIX THERAPEUTICS INC 0.55%
KODIAK SCIENCES INC 0.54%
BIOHAVEN LTD 0.52%
VERICEL CORP 0.49%
ANAPTYSBIO INC 0.49%
CAPRICOR THERAPEUTICS INC 0.49%
STOKE THERAPEUTICS INC 0.48%
MONTE ROSA THERAPEUTICS INC 0.47%
VIR BIOTECHNOLOGY INC 0.47%
HYPERLIQUID STRATEGIES 0.46%
TYRA BIOSCIENCES INC 0.41%
CORVUS PHARMACEUTICALS INC 0.41%
CULLINAN THERAPEUTICS INC 0.4%
PRECIGEN INC 0.37%
INHIBRX BIOSCIENCES INC 0.35%
TAYSHA GENE THERAPIES INC 0.35%
ARDELYX INC 0.35%
AVALO THERAPEUTICS INC 0.35%
その他 - %

このプロバイダーのその他のETF&ファンド

類似のETF&ファンド

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    純資産価値(NAV)
    {{ item.expense_ratio }}
    総経費率(TER)
登録 is required アクセスを得るために必要です。